FDA Warning Letter — Lymol Medical Corporation

Case 606833 — FEI 1221129

The FDA took a Warning Letter action against Lymol Medical Corporation on April 7, 2020 (Woburn, MA). The action was issued by CDRH and concerns devices products. This facility has 5 or more recent FDA inspections on record.

Action Details

Facility
Lymol Medical Corporation
Date
April 7, 2020
Fiscal Year
2020
Product Type
Devices
Center
CDRH
Location
Woburn, MA (United States)